Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

NSE:INDRAMEDCO Statistics

Total Valuation

NSE:INDRAMEDCO has a market cap or net worth of INR 46.26 billion. The enterprise value is 43.37 billion.

Market Cap	46.26B
Enterprise Value	43.37B

Important Dates

The next estimated earnings date is Monday, November 3, 2025.

Earnings Date	Nov 3, 2025
Ex-Dividend Date	Sep 18, 2025

Share Statistics

NSE:INDRAMEDCO has 91.67 million shares outstanding. The number of shares has decreased by -0.05% in one year.

Current Share Class	91.67M
Shares Outstanding	91.67M
Shares Change (YoY)	-0.05%
Shares Change (QoQ)	-0.02%
Owned by Insiders (%)	2.90%
Owned by Institutions (%)	7.49%
Float	40.99M

Valuation Ratios

The trailing PE ratio is 27.59 and the forward PE ratio is 24.90.

PE Ratio	27.59
Forward PE	24.90
PS Ratio	3.37
PB Ratio	7.75
P/TBV Ratio	7.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	25.87
EV / Sales	3.16
EV / EBITDA	17.13
EV / EBIT	20.97
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.05
Debt / EBITDA	0.13
Debt / FCF	n/a
Interest Coverage	33.25

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	22.66%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	4.53M
Profits Per Employee	552,488
Employee Count	3,035
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NSE:INDRAMEDCO has paid 573.60 million in taxes.

Income Tax	573.60M
Effective Tax Rate	25.49%

Stock Price Statistics

The stock price has increased by +13.98% in the last 52 weeks. The beta is 0.61, so NSE:INDRAMEDCO's price volatility has been lower than the market average.

Beta (5Y)	0.61
52-Week Price Change	+13.98%
50-Day Moving Average	472.42
200-Day Moving Average	441.40
Relative Strength Index (RSI)	65.22
Average Volume (20 Days)	201,671

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:INDRAMEDCO had revenue of INR 13.74 billion and earned 1.68 billion in profits. Earnings per share was 18.29.

Revenue	13.74B
Gross Profit	5.01B
Operating Income	2.07B
Pretax Income	2.25B
Net Income	1.68B
EBITDA	2.53B
EBIT	2.07B
Earnings Per Share (EPS)	18.29

Balance Sheet

The company has 3.22 billion in cash and 327.60 million in debt, giving a net cash position of 2.89 billion or 31.52 per share.

Cash & Cash Equivalents	3.22B
Total Debt	327.60M
Net Cash	2.89B
Net Cash Per Share	31.52
Equity (Book Value)	5.97B
Book Value Per Share	65.04
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 36.50%, with operating and profit margins of 15.06% and 12.21%.

Gross Margin	36.50%
Operating Margin	15.06%
Pretax Margin	16.38%
Profit Margin	12.21%
EBITDA Margin	18.43%
EBIT Margin	15.06%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 4.50, which amounts to a dividend yield of 0.95%.

Dividend Per Share	4.50
Dividend Yield	0.95%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	4
Payout Ratio	24.60%
Buyback Yield	0.05%
Shareholder Yield	0.99%
Earnings Yield	3.62%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1